ATC code C

## References

* v
* t
* e

Pharmacology: major drug groups

Gastrointestinal tract/
metabolism (A)|

* stomach acid
* Antacids
* H2 antagonists
* Proton pump inhibitors
* Antiemetics
* Laxatives
* Antidiarrhoeals/Antipropulsives
* Anti-obesity drugs
* Anti-diabetics
* Vitamins
* Dietary minerals

Blood and blood
forming organs (B)|

* Antithrombotics
* Antiplatelets
* Anticoagulants
* Thrombolytics/fibrinolytics
* Antihemorrhagics
* Platelets
* Coagulants
* Antifibrinolytics

Cardiovascular
system (C)|

* cardiac therapy/antianginals
* Cardiac glycosides
* Antiarrhythmics
* Cardiac stimulants
* Antihypertensives
* Diuretics
* Vasodilators
* Beta blockers
* Calcium channel blockers
* renin–angiotensin system
* ACE inhibitors
* Angiotensin II receptor antagonists
* Renin inhibitors
* Antihyperlipidemics
* Statins
* Fibrates
* Bile acid sequestrants

Skin (D)|

* Emollients
* Cicatrizants
* Antipruritics
* Antipsoriatics
* Medicated dressings

Genitourinary
system (G)|

* Hormonal contraception
* Fertility agents
* SERMs
* Sex hormones

Endocrine
system (H)|

* Hypothalamic–pituitary hormones
* Corticosteroids
* Glucocorticoids
* Mineralocorticoids
* Sex hormones
* Thyroid hormones/Antithyroid agents

Infections and
infestations (J, P, QI)|

* Antimicrobials: Antibacterials (Antimycobacterials)
* Antifungals
* Antivirals
* Antiparasitics
* Antiprotozoals
* Anthelmintics
* Ectoparasiticides
* IVIG
* Vaccines

Malignant disease
(L01–L02)|

* Anticancer agents
* Antimetabolites
* Alkylating
* Spindle poisons
* Antineoplastic
* Topoisomerase inhibitors

Immune disease
(L03–L04)|

* Immunomodulators
* Immunostimulants
* Immunosuppressants

Muscles, bones,
and joints (M)|

* Anabolic steroids
* Anti-inflammatories
* NSAIDs
* Antirheumatics
* Corticosteroids
* Muscle relaxants
* Bisphosphonates

Brain and
nervous system (N)|

* Analgesics
* Anesthetics
* General
* Local
* Anorectics
* Anti-ADHD agents
* Antiaddictives
* Anticonvulsants
* Antidementia agents
* Antidepressants
* Antimigraine agents
* Antiparkinson agents
* Antipsychotics
* Anxiolytics
* Aphrodisiacs
* Depressants
* Entactogens
* Entheogens
* Euphoriants
* Hallucinogens
* Psychedelics
* Dissociatives
* Deliriants
* Hypnotics/Sedatives
* Mood Stabilizers
* Neuroprotectives
* Nootropics
* Neurotoxins
* Orexigenics
* Serenics
* Stimulants
* Wakefulness-promoting agents

Respiratory
system (R)|

* Decongestants
* Bronchodilators
* Cough medicines
* H1 antagonists

Sensory organs (S)|

* Ophthalmologicals
* Otologicals

Other ATC (V)|

* Antidotes
* Contrast media
* Radiopharmaceuticals
* Dressings
* Senotherapeutics

* v
* t
* e

Cardiac glycosides (C01A)

Bufadienolides|

| Bufo|

* Arenobufagin
* Bufotalin
* Cinobufagin
* Marinobufagin

|

Scilla|

* Proscillaridin
* Scilliroside

Kalanchoe|

* Daigremontianin

Cardenolides|

| Digitalis|

* Acetyldigitoxin
* Acetyldigoxin
* Digitoxin#
* Digoxin#
* Lanatoside C
* Deslanoside
* Metildigoxin
* Gitoformate

|

Strophanthus|

* Ouabain (g-Strophanthin)
* k-Strophanthin
* Cymarin

Thevetia|

* Peruvoside

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Antiarrhythmic agents (C01B)

Channel blockers|

| class I
(Na+ channel blockers)|

| class Ia (Phase 0→ and Phase 3→)|

* Ajmaline
* Disopyramide
* Hydroquinidine
* Lorajmine
* Prajmaline
* Procainamide#
* Quinidine#
* Sparteine

|

class Ib (Phase 3←)|

* IV
* Lidocaine#
* enteral
* Aprindine
* Mexiletine
* Tocainide

class Ic (Phase 0→)|

* Encainide‡
* Ethacizine
* Flecainide
* Indecainide‡
* Lorcainide
* Moracizine‡
* Propafenone

class III
(Phase 3→, K+ channel blockers)|

* Amiodarone
* Bretylium
* Bunaftine
* Celivarone†
* Dofetilide
* Dronedarone
* E-4031†
* Ibutilide
* Nifekalant
* Sotalol
* Tedisamil
* Vernakalant

class IV
(Phase 4→, Ca2+ channel blockers)|

* Diltiazem
* Verapamil#

Receptor agonists<BR>and antagonists|

| class II
(Phase 4→, β blockers)|

* Nadolol
* Pindolol
* Propranolol
* cardioselective
* Acebutolol
* Atenolol
* Esmolol
* Metoprolol

|

A1 agonist|

* Adenosine
* Benzodiazepines
* Barbiturates

M2|

* muscarinic antagonist: Atropine
* Disopyramide
* Quinidine
muscarinic agonist: Digoxin

α receptors|

* Amiodarone
* Bretylium
* Quinidine
* Verapamil

Ion transporters|

| Na+/ K+-ATPase|

* Digitoxin
* Digoxin
* Ouabain

|

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Cardiac stimulants excluding cardiac glycosides (C01C)

Adrenergic and
dopaminergic agents|

| Adrenergic agonists|

| α|

* Metaraminol
* Phenylephrine
* Methoxamine
* Norfenefrine
* Oxedrine
* Midodrine
* Mephentermine

|

* Dobutamine
* Arbutamine
* Isoprenaline
* Prenalterol

mixed|

* Amezinium metilsulfate
* Droxidopa
* Epinephrine #
* Norepinephrine
* Etilefrine

Dopamine agonists|

* Fenoldopam

Both|

* Dopamine #
* Dopexamine
* Ibopamine
* Octopamine

Unknown/ungrouped|

* Dimetofrine
* Gepefrine
* Cafedrine
* Theodrenaline

Phosphodiesterase inhibitors (PDE3I)|

* Amrinone
* Milrinone
* Enoximone
* Bucladesine

Other cardiac stimulants|

* Angiotensinamide
* Xamoterol
* Levosimendan
* Pimobendan

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Vasodilators used in cardiac diseases (C01D)

Nitrovasodilators|

* Nitroglycerin #
* Isosorbide dinitrate #
* Isosorbide mononitrate
* Itramin tosilate
* Linsidomine
* Molsidomine
* Nicorandil
* Pentaerythritol tetranitrate
* Propatylnitrate
* Tenitramine
* Trolnitrate

Quinolone vasodilators|

* Flosequinan‡

Others|

* Benziodarone
* Carbocromen
* Cinepazet
* Cloridarol
* Dilazep
* Efloxate
* Etafenone
* Gapicomine
* Heptaminol
* Hexobendine
* Imolamine
* Levosimendan
* Nesiritide
* Nicorandil
* Oxyfedrine
* Pimobendan
* Prenylamine
* Serelaxin
* Trapidil

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Sympatholytic (and closely related) antihypertensives (C02)

Sympatholytics
(antagonize α-adrenergic
vasoconstriction)|

| Central|

| α2 agonist|

* Clonidine
* Guanabenz
* Guanfacine
* Methyldopa#
* Tiamenidine‡

|

Adrenergic release inhibitors|

* Bethanidine
* Bretylium
* Debrisoquine
* Guanadrel
* Guanazodine
* Guanethidine
* Guanoclor
* Guanoxabenz
* Guanoxan

Imidazoline receptor agonist|

* Moxonidine
* Rilmenidine
* Tolonidine

Ganglion-blocking/nicotinic antagonist|

* Hexamethonium‡
* Mecamylamine
* Pentolinium
* Trimethaphan

Peripheral|

| Indirect|

| MAOI|

* Pargyline‡

|

Adrenergic uptake inhibitor|

* Bietaserpine
* Deserpidine
* Methoserpidine
* Rescinnamine
* Reserpine
* Syrosingopine

Tyrosine hydroxylase inhibitor|

* Metirosine

Direct|

| α1 blockers|

* Prazosin
* Indoramin
* Trimazosin
* Doxazosin
* Urapidil

|

Non-selective α blocker|

* Phentolamine

Other antagonists|

| Serotonin antagonist|

* Ketanserin
* Lidanserin

|

Endothelin antagonist (for PH)|

* dual (Bosentan, Macitentan)
* selective (Ambrisentan, Sitaxentan)

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Nonsympatholytic vasodilatory antihypertensives (C02)

Nitrovasodilator|

| NO (arterioles and venules)|

* Nitroprusside #

|

N (arteriolar)|

* Hydrazines
* Hydralazine #
* Dihydralazine
* Endralazine
* Cadralazine
* Pildralazine

(arteriolar) Potassium channel opener|

* Minoxidil
* Diazoxide

(arteriolar) Calcium channel blocker|

* see list

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Antihypertensives: diuretics (C03)

Sulfonamides
(and etacrynic acid)|

| CA inhibitors (at PT)|

* Acetazolamide

|

Loop (Na-K-Cl at AL)|

* Furosemide#
* Azosemide
* Bumetanide
* Etacrynic acid
* Etozolin
* Muzolimine
* Ozolinone
* Piretanide
* Tienilic acid
* Torasemide

[[Chemistry:ThiThiazides (Sodium-chloride Na-Cl at Distal convoluted tubule|DCT]],
Calcium-sparing)|

* Altizide
* Bendroflumethiazide
* Butizide
* Chlorothiazide
* Cyclopenthiazide
* Cyclothiazide
* Epitizide
* Hydrochlorothiazide#
* Hydroflumethiazide
* Mebutizide
* Methyclothiazide
* Polythiazide
* Trichlormethiazide

Thiazide-likes (primarily DCT)|

* Quinethazone
* Clopamide
* Chlortalidone
* Mefruside
* Clofenamide
* Metolazone
* Meticrane
* Xipamide
* Indapamide
* Clorexolone
* Fenquizone

Potassium-sparing (at CD)|

| ESC blockers|

* Amiloride#
* Triamterene
* Benzamil

|

Aldosterone antagonists|

* Spirolactones
* Spironolactone#
* Eplerenone
* Potassium canrenoate
* Canrenone

* Nonsteroidal
* Finerenone

Osmotic diuretics (PT, DL)|

* Mannitol#
* Glycerol
* Urea

Vasopressin receptor inhibitors
(DCT and CD)|

* Vaptans
* Conivaptan
* Mozavaptan
* Satavaptan
* Tolvaptan

* Others
* Demeclocycline
* Lithium carbonate

Other|

* Ethanol, Isopropanol, 2M2B
* mercurial diuretics (Chlormerodrin, Mersalyl, Meralluride)
* Theobromine
* Cicletanine

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Peripheral vasodilators (C04)

Phenylethanolamine derivatives|

* Isoxsuprine
* Buphenine
* Bamethan

Alpha blockers|

* Non-selective
* Tolazoline
* Phentolamine
* Selective α1-blockers
* Alfuzosin
* Doxazosin
* Prazosin
* Silodosin
* Tamsulosin
* Terazosin

Niacin and derivatives|

* Niacin
* Nicotinyl alcohol
* Inositol nicotinate
* Ciclonicate

Purine derivatives|

* Pentifylline
* Xantinol nicotinate
* Pentoxifylline
* Etofylline nicotinate

Ergot alkaloids|

* Ergoloid
* Nicergoline
* Dihydroergocristine

Other peripheral vasodilators|

* Cyclandelate
* Phenoxybenzamine
* Vincamine
* Moxisylyte
* Bencyclane
* Vinburnine
* Sulcotidil
* Buflomedil
* Naftidrofuryl
* Butalamine
* Visnadine
* Cetiedil
* Cinepazide
* Ifenprodil
* Azapetine
* Fasudil

* v
* t
* e

Vasoprotectives (C05)

Antihemorrhoidals for topical use|

| corticosteroids|

* Hydrocortisone
* Prednisolone
* Betamethasone
* Fluorometholone
* Fluocortolone
* Dexamethasone
* Fluocinolone acetonide
* Fluocinonide

|

local anesthetics|

* Lidocaine
* Tetracaine
* Benzocaine
* Dibucaine
* Procaine
* Oxetacaine
* Pramocaine

other|

* Tribenoside

Antivaricose therapy|

| heparins or heparinoids for topical use|

* Organo-heparinoid
* Sodium apolate
* Heparin
* Pentosan polysulfate

|

sclerosing agents for local injection|

* Monoethanolamine oleate
* Polidocanol
* Inverted sugar syrup
* Sodium tetradecyl sulfate
* Phenol

other|

* Calcium dobesilate

Capillary stabilising agents|

| bioflavonoids|

* Rutoside
* Monoxerutin
* Diosmin
* Troxerutin
* Hidrosmin

|

other|

* Tribenoside
* Etamsylate

* v
* t
* e

Beta blockers (C07)

β, non-selective|

* Alprenolol
* Bopindolol
* Bupranolol
* Carteolol
* Cloranolol
* Mepindolol
* Nadolol
* Oxprenolol
* Penbutolol
* Pindolol/Iodopindolol
* Propranolol
* Sotalol
* Tertatolol
* Timolol

β1-selective|

* Acebutolol
* Atenolol
* Betaxolol
* Bevantolol
* Bisoprolol
* Celiprolol
* Epanolol
* Esmolol
* Landiolol
* Metoprolol
* Nebivolol
* Practolol
* S-Atenolol
* Talinolol

β2-selective|

* Butaxamine

α1\- + β-selective|

* Arotinolol
* Carvedilol
* Labetalol

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Ion channel modulators

Calcium|

| VDCCs|

| Blockers|

* L-type-selective: Dihydropyridines: Amlodipine
* Aranidipine
* Azelnidipine
* Barnidipine
* Clevidipine
* Cronidipine
* Darodipine
* Dexniguldipine
* Elgodipine
* Elnadipine
* Felodipine
* Flordipine
* Furnidipine
* Iganidipine
* Isradipine
* Lacidipine
* Lemildipine
* Lercanidipine
* Levamlodipine
* Levniguldipine
* Manidipine
* Mepirodipine
* Mesudipine
* Nicardipine
* Nifedipine
* Niguldipine
* Niludipine
* Nilvadipine
* Nimodipine
* Nisoldipine
* Nitrendipine
* Olradipine
* Oxodipine
* Palonidipine
* Pranidipine
* Ryodipine (riodipine)
* Sagandipine
* Sornidipine
* Teludipine
* Tiamdipine
* Trombodipine
* Vatanidipine; Diltiazem derivatives: Clentiazem
* Diltiazem
* Iprotiazem
* Nictiazem
* Siratiazem; Phenylalkylamines: Anipamil
* Dagapamil
* Devapamil
* Dexverapamil
* Emopamil
* Etripamil
* Falipamil
* Gallopamil
* Levemopamil
* Nexopamil
* Norverapamil
* Ronipamil
* Tiapamil
* Verapamil; Others: AH-1058
* Brinazarone
* Budiodarone
* Celivarone
* Cyproheptadine
* Dronedarone
* Fantofarone
* SR-33805
* Tetrahydropalmatine

* N-type-selective: ω-Conotoxins
* ω-Conotoxin GVIA
* Caroverine
* Huwentoxin XVI
* Leconotide (ω-conotoxin CVID)
* PD-173212
* Ralfinamide
* Safinamide
* Z160
* Ziconotide (ω-conotoxin MVIIA)

* P-type-selective: ω-Agatoxin IVA
* ω-Agatoxin IVB

* R-type-selective: SNX-482

* T-type-selective: ABT-639
* ML-218
* Niflumic acid
* NNC 55-0396
* ProTx I
* Z944
* Zonisamide

* Non-selective: ω-Agatoxin TK
* ω-Conotoxin MVIIC
* Benidipine
* Bepridil
* Cilnidipine
* Cinnarizine
* Dotarizine
* Efonidipine
* Flunarizine
* Lamotrigine
* Levetiracetam
* Lomerizine
* Loperamide
* Mibefradil
* NP078585
* Ruthenium red
* TROX-1

* α2δ subunit-selective (gabapentinoids): 4-Methylpregabalin
* Arbaclofen
* Arbaclofen placarbil
* Atagabalin
* Baclofen
* Gabapentin
* Gabapentin enacarbil
* Imagabalin
* Mirogabalin
* PD-200,347
* PD-217,014
* PD-299,685
* Phenibut
* Pregabalin

* Others/unsorted: Bencyclane
* Berbamine
* Bevantolol
* Canadine
* Carboxyamidotriazole
* Cycleanine
* Dauricine
* Dimeditiapramine
* Diproteverine
* Enpiperate
* Eperisone
* Elpetrigine
* Ethadione
* Ethanol (alcohol)
* Ethosuximide
* Fasudil
* Fendiline
* Fostedil
* Imepitoin
* JTV-519
* Lidoflazine
* Magnesium
* Manoalide
* Mesuximide
* Monatepil
* Naftopidil
* Ochratoxin A
* Osthol
* Otilonium bromide
* Paramethadione
* Phensuximide
* Pinaverium bromide
* Prenylamine
* Rhynchophylline
* Sesamodil
* Silperisone
* Sipatrigine
* Terodiline
* Tetrandrine
* Tolperisone
* Trimethadione
* Valperinol

|

Activators|

* L-type-selective: Bay K8644

Potassium|

| VGKCs|

| Blockers|

* 3,4-Diaminopyridine (amifampridine)
* 4-Aminopyridine (fampridine/dalfampridine)
* Adekalant
* Almokalant
* Amiodarone
* Azimilide
* Bretylium
* Bunaftine
* Charybdotoxin
* Clamikalant
* Conotoxins
* Dalazatide
* Dendrotoxin
* Dofetilide
* Dronedarone
* E-4031
* Hanatoxin
* HgeTx1
* HsTx1
* Ibutilide
* Inakalant
* Kaliotoxin
* Linopirdine
* Lolitrem B
* Maurotoxin
* Nifekalant
* Notoxin
* Paxilline
* Pinokalant
* Quinidine
* ShK-186
* Sotalol
* Tedisamil
* Terikalant
* Tetraethylammonium
* Vernakalant

* hERG (KCNH2, Kv11.1)-specific: Ajmaline
* Amiodarone
* AmmTX3
* Astemizole
* Azaspiracid
* AZD1305
* Azimilide
* Bedaquiline
* BeKm-1
* BmTx3
* BRL-32872
* Chlorpromazine
* Cisapride
* Clarithromycin
* Darifenacin
* Dextropropoxyphene
* Diallyl trisulfide
* Domperidone
* E-4031
* Ergtoxins
* Erythromycin
* Gigactonine
* Haloperidol
* Ketoconazole
* Norpropoxyphene
* Orphenadrine
* Pimozide
* PNU-282,987
* Promethazine
* Quinidine
* Ranolazine
* Roxithromycin
* Sertindole
* Solifenacin
* Tamulotoxin
* Terodiline
* Terfenadine
* Thioridazine
* Tolterodine
* Vanoxerine
* Vernakalant

* KCNQ (Kv7)-specific: Linopirdine
* XE-991
* Spooky toxin (SsTx)

|

Activators|

* KCNQ (Kv7)-specific: Flupirtine
* Retigabine

IRKs|

| Blockers|

* KATP-specific: Acetohexamide
* Carbutamide
* Chlorpropamide
* Glibenclamide (glyburide)
* Glibornuride
* Glicaramide
* Gliclazide
* Glimepiride
* Glipizide
* Gliquidone
* Glisoxepide
* Glyclopyramide
* Glycyclamide
* Metahexamide
* Mitiglinide
* Nateglinide
* Repaglinide
* Tolazamide
* Tolbutamide

* GIRK-specific: Barium
* Caramiphen
* Cloperastine
* Clozapine
* Dextromethorphan
* Ethosuximide
* Ifenprodil
* Tertiapin
* Tipepidine

|

Activators|

* KATP-specific: Aprikalim
* Bimakalim
* Cromakalim
* Diazoxide
* Emakalim
* Levcromakalim
* Mazokalim
* Minoxidil
* Naminidil
* Nicorandil
* Pinacidil
* Rilmakalim
* Sarakalim

* GIRK-specific: ML-297 (VU0456810)

KCa|

| Blockers|

* BKCa-specific: Ethanol (alcohol)
* GAL-021

|

Activators|

* BKCa-specific: Flufenamic acid
* Meclofenamic acid
* Niflumic acid
* Nimesulide
* Rottlerin (mallotoxin)
* Tolfenamic acid

K2Ps|

| Blockers|

* 12-O-Tetradecanoylphorbol-13-acetate
* Arachidonic acid
* Fluoxetine
* Norfluoxetine

|

Activators|

* Riluzole

Sodium|

| VGSCs|

| Blockers|

* Antianginals: Ranolazine

* Antiarrhythmics (class I): Ajmaline
* Aprindine
* Disopyramide
* Dronedarone
* Encainide
* Flecainide
* Lidocaine
* Lorajmine
* Lorcainide
* Mexiletine
* Moricizine
* Pilsicainide
* Prajmaline
* Procainamide
* Propafenone
* Quinidine
* Sparteine
* Tocainide

* Anticonvulsants: Acetylpheneturide
* Carbamazepine
* Cenobamate
* Chlorphenacemide
* Elpetrigine
* Eslicarbazepine acetate
* Ethotoin
* Fosphenytoin
* Lacosamide
* Licarbazepine
* Mephenytoin
* Oxcarbazepine
* Oxitriptyline
* Phenacemide
* Pheneturide
* Phenytoin
* Rufinamide
* Sipatrigine
* Topiramate
* Sodium valproate
* Valnoctamide
* Valproate pivoxil
* Valproate semisodium
* Valproic acid
* Valpromide
* Zonisamide

* Local anesthetics: pFBT
* Amylocaine
* Articaine
* Benzocaine
* Bupivacaine (Levobupivacaine, Ropivacaine)
* Butacaine
* Butamben
* Chloroprocaine
* Cinchocaine
* Cocaine
* Cyclomethycaine
* Dimethocaine
* Diphenhydramine
* Etidocaine
* Hexylcaine
* Iontocaine
* Lidocaine
* Mepivacaine
* Meprylcaine
* Metabutoxycaine
* Orthocaine
* Piperocaine
* Prilocaine
* Procaine
* Propoxycaine
* Proxymetacaine
* Risocaine
* Tetracaine
* Trimecaine

* Analgesics: AZD-3161
* DSP-2230
* Funapide
* GDC-0276
* NKTR-171
* PF-04531083
* PF-05089771
* Ralfinamide
* Raxatrigine
* RG7893 (GDC-0287)

* Toxins: Conotoxins
* Neosaxitoxin
* Saxitoxin
* Tetrodotoxin
* Zetekitoxin AB

* Others: Buprenorphine
* Evenamide
* Menthol (mint)
* Safinamide
* Tricyclic antidepressants

|

Activators|

* Aconitine
* Atracotoxins (ω-Atracotoxin, Robustoxin, Versutoxin)
* Batrachotoxin
* Ciguatoxins
* Grayanotoxins
* Poneratoxin

ENaC|

| Blockers|

* Amiloride
* Benzamil
* Triamterene

|

Activators|

* Solnatide

ASICs|

| Blockers|

* A-317567
* Amiloride
* Aspirin
* Ibuprofen
* PcTX1

|

Chloride|

| CaCCs|

| Blockers|

* Crofelemer
* DIDS
* Ethacrynic acid
* Flufenamic acid
* Fluoxetine
* Furosemide
* Glibenclamide
* Mefloquine
* Mibefradil
* Niflumic acid

|

Activators|

* Carbachol

CFTR|

| Blockers|

* Glibenclamide
* Lonidamine
* Piretanide

|

Activators|

* 1,7-Phenanthroline
* 1,10-Phenanthroline
* 4,7-Phenanthroline
* 7,8-Benzoquinoline
* Ivacaftor
* Phenanthridine

Unsorted|

| Blockers|

* Bumetanide
* Flufenamic acid
* Meclofenamic acid
* Mefenamic acid
* Mepacrine
* Niflumic acid
* Talniflumate
* Tolfenamic acid
* Trifluoperazine

|

Others|

| TRPs|

* See here instead.

|

LGICs|

* See here instead.

See also: Receptor/signaling modulators • Transient receptor potential channel modulators

* v
* t
* e

Antihypertensives: agents acting on the renin–angiotensin system (C09)

ACE inhibitors
("-pril")|

* Sulfhydryl-containing: Captopril
* Rentiapril
* Zofenopril

* Dicarboxylate-containing: Enalapril<sup>#
* Benazepril
* Cilazapril
* Delapril
* Imidapril
* Lisinopril (+HCT)
* Moexipril
* Perindopril (+indapamide)
* Quinapril (+HCT)
* Ramipril
* Spirapril
* Temocapril
* Trandolapril

* Phosphonate-containing: Ceronapril
* Fosinopril (+HCT)

* Other/ungrouped: Alacepril

AIIRAs
("-sartan")|

* Azilsartan
* Candesartan
* Eprosartan
* Fimasartan
* Irbesartan
* Losartan (+HCT)
* Olmesartan (+amlodipine)
* Tasosartan§
* Telmisartan (+HCT)
* Valsartan (+HCT, +amlodipine)

Renin inhibitors
("-kiren")|

* Aliskiren (+amlodipine, +amlodipine and HCT)
* Remikiren§

Dual ACE/NEP inhibitors|

* Gemopatrilat
* Ilepatril
* Omapatrilat
* Sampatrilat

Neprilysin inhibitors|

* Sacubitril (+valsartan)

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

* v
* t
* e

Lipid-modifying agents (C10)

GI tract|

| Cholesterol absorption inhibitors, NPC1L1|

* Ezetimibe
* SCH-48461

|

Bile acid sequestrants/resins (LDL)|

* Colesevelam
* Colestilan
* Colestipol
* Colestyramine
* Colextran

Liver|

| Statins (HMG-CoA reductase, LDL)|

* Atorvastatin
* Cerivastatin‡
* Fluvastatin
* Lovastatin
* Mevastatin
* Pitavastatin
* Pravastatin
* Rosuvastatin
* Simvastatin#

|

Niacin and derivatives (HDL and LDL)|

* Acipimox
* Aluminium nicotinate
* Niacin
* Niceritrol
* Nicofuranose
* Nicotinyl alcohol

MTTP inhibitors (VLDL)|

* Dirlotapide
* Lomitapide
* Mitratapide

ATP citrate lyase inhibitors (LDL)|

* Bempedoic acid†

Blood vessels|

| Fibrates (PPAR)|

* Aluminium clofibrate
* Bezafibrate
* Ciprofibrate
* Clinofibrate
* Clofibrate‡
* Clofibride
* Etofibrate
* Fenofibrate
* Gemfibrozil
* Pemafibrate
* Ronifibrate
* Simfibrate

|

CETP inhibitors (HDL)|

* Anacetrapib†
* Dalcetrapib§
* Evacetrapib§
* Obicetrapib†
* Torcetrapib§

PCSK9 inhibitors (LDL)|

* Alirocumab
* Bococizumab
* Evolocumab

Combinations|

* Ezetimibe/atorvastatin
* Ezetimibe/simvastatin
* Niacin/laropiprant
* Niacin/lovastatin
* Niacin/simvastatin

Other|

* Alipogene tiparvovec
* Azacosterol
* Azalanstat
* Benfluorex‡
* Darapladib§
* Dextrothyroxine‡
* Lapaquistat§
* Magnesium pyridoxal 5-phosphate glutamate
* Meglutol
* Mipomersen
* Omega-3-triglycerides
* Policosanol
* Probucol
* Tiadenol
* Triparanol‡
* Volanesorsen†

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/ATC code C. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:ATC_code_C&oldid=40716"
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template
*[VDCCs]: Voltage-dependent calcium channels
*[VGKCs]: Voltage-gated potassium channels
*[IRKs]: Inwardly rectifying potassium channel
*[KATP]: ATP-sensitive potassium channel
*[GIRK]: G protein-coupled inwardly-rectifying potassium channel
*[KCa]: Calcium-activated potassium channel
*[K2Ps]: Tandem pore domain potassium channel
*[VGSCs]: Voltage-gated sodium channels
*[ENaC]: Epithelial sodium channel
*[ASICs]: Acid-sensing ion channel
*[CaCCs]: Calcium-activated chloride channel
*[CFTR]: Cystic fibrosis transmembrane conductance regulator
*[TRPs]: Transient receptor potential channels
*[LGICs]: Ligand gated ion channels